↓ Skip to main content

Cochrane Database of Systematic Reviews

Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

Overview of attention for article published in Cochrane database of systematic reviews, February 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 tweeters
facebook
1 Facebook page
f1000
1 research highlight platform

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
205 Mendeley
citeulike
1 CiteULike
Title
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
Published in
Cochrane database of systematic reviews, February 2014
DOI 10.1002/14651858.cd005441.pub3
Pubmed ID
Authors

Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud, Lise Lotte Gluud

Abstract

Pegylated interferon (peginterferon) plus ribavirin is the recommended treatment for patients with chronic hepatitis C, but systematic assessment of the effect of this treatment compared with interferon plus ribavirin is needed.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 205 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Spain 1 <1%
United Kingdom 1 <1%
Unknown 201 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 39 19%
Student > Bachelor 26 13%
Student > Ph. D. Student 25 12%
Researcher 21 10%
Student > Postgraduate 14 7%
Other 36 18%
Unknown 44 21%
Readers by discipline Count As %
Medicine and Dentistry 77 38%
Nursing and Health Professions 21 10%
Psychology 16 8%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Agricultural and Biological Sciences 6 3%
Other 28 14%
Unknown 50 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2017.
All research outputs
#5,288,709
of 17,829,175 outputs
Outputs from Cochrane database of systematic reviews
#7,667
of 11,769 outputs
Outputs of similar age
#56,030
of 195,469 outputs
Outputs of similar age from Cochrane database of systematic reviews
#142
of 203 outputs
Altmetric has tracked 17,829,175 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 11,769 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.3. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,469 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 203 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.